Evidence map›Paper›PMID 39283345›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2025

Nested CNN architecture for three-dimensional dose distribution prediction in tomotherapy for prostate cancer.

Maryam Zamanian, Maziar Irannejad, Iraj Abedi, Mohsen Saeb, Mahnaz Roayaei

Abstract read
PubMed Publisher
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maryam ZamanianDepartment of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Maziar IrannejadDepartment of Electrical Engineering, Islamic Azad University Najafabad Branch, Najafabad, Iran.
Iraj AbediDepartment of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. i.abedi@med.mui.ac.ir.ORCID 0000-0001-8094-0438
Mohsen SaebDepartment of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Mahnaz RoayaeiDepartment of Radiation Oncology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe hypothesis of changing network layers to increase the accuracy of dose distribution prediction, instead of expanding their dimensions, which requires complex calculations, has been considered in our study. MATERIALS AND

methodsA total of 137 prostate cancer patients treated with the tomotherapy technique were categorized as 80% training and validating as well as 20% testing for the nested UNet and UNet architectures. Mean absolute error (MAE) was used to measure the dosimetry indices of dose-volume histograms (DVHs), and geometry indices, including the structural similarity index measure (SSIM), dice similarity coefficient (DSC), and Jaccard similarity coefficient (JSC), were used to evaluate the isodose volume (IV) similarity prediction. To verify a statistically significant difference, the two-way statistical Wilcoxon test was used at a level of 0.05 (p < 0.05).

resultsUse of a nested UNet architecture reduced the predicted dose MAE in DVH indices. The MAE for planning target volume (PTV), bladder, rectum, and right and left femur were D

conclusionThe nested UNet network can be considered a suitable network due to its ability to improve the accuracy of dose distribution prediction compared to the UNet network in an acceptable time.

Indexed as

Neural Networks, ComputerProstatic NeoplasmsRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedHumansMaleRadiotherapy DosageHelical tomotherapyNested U‑Net architectureProstate cancerThree-dimensional dose predictionU‑Net architecture

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.